Seres Therapeutics
MCRB
MCRB
80 hedge funds and large institutions have $494M invested in Seres Therapeutics in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.06% more ownership
Funds ownership: 3.74% → 3.8% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
80% less call options, than puts
Call options by funds: $1.8M | Put options by funds: $8.84M
Holders
80
Holding in Top 10
1
Calls
$1.8M
Puts
$8.84M
Top Buyers
| 1 | +$3.52M | |
| 2 | +$2.45M | |
| 3 | +$2.17M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$2.05M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.76M |
Top Sellers
| 1 | -$1.84M | |
| 2 | -$1.8M | |
| 3 | -$1.44M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$1.41M |
| 5 |
AG
Artal Group
Luxembourg
|
-$802K |